FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091863 [Registered on: 28/07/2025] Trial Registered Prospectively
Last Modified On: 27/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Compare Effects Of Ketamine And Midazolam Given As Nasal Drops Before Surgery In Children  
Scientific Title of Study   A Comparative Evaluation Of Intranasal Ketamine And Intranasal Midazolam For Premedication In Children  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vishal Pratap Singh 
Designation  Junior Resident 
Affiliation  Shri Guru Ram Rai Institute Of Medical And Health Sciences 
Address  Department Of Anaesthesia Shri Guru Ram Rai Institute Of Medical And Health Sciences Patel Nagar Dehradun
Shri Guru Ram Rai Institute Of Medical And Health Sciences Patel Nagar Dehradun
Dehradun
UTTARANCHAL
248001
India 
Phone  9897560328  
Fax    
Email  singhpratap50vishal@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Kanika Sachdeva 
Designation  Associate Professor 
Affiliation  Shri Guru Ram Rai Institute Of Medical And Health Sciences 
Address  Department Of Anaesthesia Shri Guru Ram Rai Institute Of Medical And Health Sciences Patel Nagar Dehradun
Shri Guru Ram Rai Institute Of Medical And Health Sciences Patel Nagar Dehradun
Dehradun
UTTARANCHAL
248001
India 
Phone  9899440374  
Fax    
Email  kanikasachdeva17@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Vishal Pratap Singh 
Designation  Junior Resident 
Affiliation  Shri Guru Ram Rai Institute Of Medical And Health Sciences 
Address  Department Of Anaesthesia Shri Guru Ram Rai Institute Of Medical And Health Sciences Patel Nagar Dehradun
Shri Guru Ram Rai Institute Of Medical And Health Sciences Patel Nagar Dehradun
Dehradun
UTTARANCHAL
248001
India 
Phone  9897560328  
Fax    
Email  singhpratap50vishal@gmail.com  
 
Source of Monetary or Material Support  
Shri Guru Ram Rai Institute Of Medical And Health Sciences Patel Nagar Dehradun Uttaranchal India PIN Code 248001 
 
Primary Sponsor  
Name  Shri Guru Ram Rai Institute Of Medical And Health Sciences 
Address  Shri Guru Ram Rai Institute Of Medical And Health Sciences Patel Nagar Dehradun Uttaranchal India PIN code 248001 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vishal Pratap Singh  Shri Guru Ram Rai Institute Of Medical And Health Sciences  Department Of Anaesthesia Shri Guru Ram Rai Institute Of Medical And Health Sciences Patel Nagar
Dehradun
UTTARANCHAL 
9897560328

pranjal.mamgain@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee (IEC) Shri Guru Ram Rai Institute Of Medical And Health Sciences Patel Nagar Dehradun  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K409||Unilateral inguinal hernia, without obstruction or gangrene,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Intranasal Ketamine  Intranasal Ketamine 5 Milligrams Per Kilogram Given Before 10 Minutes Shifting To Operation Theatre  
Comparator Agent  Intranasal Midazolam  Intranasal Midazolam 0.2 Milligrams Per Kilogram Given 10 Minutes Before Shifting To Operation Theatre 
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  8.00 Year(s)
Gender  Both 
Details  Weight between 10 To 20 Kilogram And ASA Class One 
 
ExclusionCriteria 
Details  Emergency Surgeries And Patients Allergic To Study Drugs 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
Parent Separation Score  Baseline (10 Minutes Before Shifting To Operation Theatre) 
 
Secondary Outcome  
Outcome  TimePoints 
Mask Acceptance Score  Immediate Preoperatively 
Generalised Anxiety Score  Immediate Preoperatively 
Vital Parameters   Perioperative Period Till 24 Hours 
Drug Related Complications  Till 24 Hours Postoperatively 
Ramsay Sedation Score   Immediate Preoperatively Before Shifting To Operation Theatre to 24 hours Postoperatively 
 
Target Sample Size   Total Sample Size="72"
Sample Size from India="72" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   09/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [Kanika.mamgain@gmail.com].

  6. For how long will this data be available start date provided 01-03-2026 and end date provided 01-01-2031?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   A Comparative Evaluation Of Intranasal Ketamine And Intranasal Midazolam For Premedication In Children Aged Between Three To Eight Years Coming To Shri Guru Ram Rai Institute Of Medical And Health Sciences For Elective Paediatric Surgeries Will Be Conducted And Parent Separation Score Will Be Seen As Primary Outcome. Mask Acceptance Score Generalised Anxiety Score And Ramsay Sedation Score Will Be Evaluated As Secondary Outcome In Seventy Two Patients After Taking Written Informed Consent 
Close